APOC1 and metabolic syndrome: A first study was conducted in patients with metabolic syndrome and demonstrated that high plasma levels of apoC1 were associated with increased carotid wall thickness only in the subgroup presenting with systemic inflammation (hsCRP > 3 mg/L) [150].